STOCK TITAN

Insider at FENC (FENC) plans sale of 10,349 shares after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider associated with FENC has filed a notice of intent to sell 10,349 common shares through Morgan Stanley Smith Barney LLC on or around 02/02/2026, with the shares to be sold on NASDAQ.

The shares were acquired the same day via a stock option exercise paid in cash. Over the prior three months, the same seller, Rostislav Raykov, sold additional blocks of common stock totaling 30,312 shares for gross proceeds of about $235,000. The issuer had 28,116,829 shares outstanding when this notice was prepared.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the latest Form 144 filing for FENC disclose?

The filing discloses an insider’s intent to sell 10,349 common shares of FENC through Morgan Stanley Smith Barney LLC around 02/02/2026 on NASDAQ. These shares were acquired the same day via a cash stock option exercise from the issuer.

Who is selling shares in the FENC Form 144 and how many?

The seller named is Rostislav Raykov, who plans to sell 10,349 common shares of FENC. The sale is to be executed through Morgan Stanley Smith Barney LLC, using its Executive Financial Services division at 1 New York Plaza, New York.

How were the FENC shares being sold in this Form 144 acquired?

The 10,349 FENC common shares to be sold were acquired on 02/02/2026 via a stock option exercise from the issuer. Payment for these shares was made in cash on the same date, according to the Form 144 disclosure table.

What prior FENC share sales has this insider reported in the last 3 months?

Over the past three months, Rostislav Raykov reported three FENC common stock sales: 10,000 shares on 11/05/2025, 10,000 shares on 12/05/2025, and 10,312 shares on 01/02/2026, for total gross proceeds of roughly $235,000.

What is the aggregate market value and share count context in the FENC Form 144?

The planned sale of 10,349 common shares has an aggregate market value of about $80,339.29. The issuer reported 28,116,829 shares outstanding when this notice was prepared, providing context for the relative size of the proposed sale.

On which exchange will the FENC shares in this Form 144 be sold?

The Form 144 states that the 10,349 common shares of FENC are expected to be sold on the NASDAQ market. The executing broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York.
Fennec Pharmaceuticals Inc

NASDAQ:FENC

FENC Rankings

FENC Latest News

FENC Latest SEC Filings

FENC Stock Data

261.62M
28.96M
16.25%
57.88%
4.48%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
RESEARCH TRIANGLE PARK